نتایج جستجو برای: hypoglycemic agents

تعداد نتایج: 362642  

2017
Subhankar Chowdhury Partha Pratim Chakraborty

A significant bulk of people living with diabetes is on insulin therapy aiming for satisfactory glycemic control and resultant reduction in vascular complications of diabetes. Insulin undoubtedly is the most potent antihyperglycemic agent. However, a significant proportion of insulin-treated diabetics fails to achieve the desired glycemic goal. Errors of insulin therapy remain an important and ...

Journal: :Diabetes technology & therapeutics 2011
Chidambarann Sudhakaran Utkal Kishore Ranjit Mohan Anjana Ranjit Unnikrishnan Viswanathan Mohan

BACKGROUND this study reports on the effectiveness of sitagliptin in Asian Indian type 2 diabetes patients seen at a tertiary diabetes care center who had inadequate glycemic control with oral hypoglycemic agents either alone or in combination, compared to a group of patients who received insulin glargine. PATIENTS AND METHODS patients with type 2 diabetes mellitus (n = 2,817) whose glycemia ...

Journal: :Diabetes care 2007
Nanne Kleefstra Sebastiaan T Houweling Stephan J L Bakker Simon Verhoeven Rijk O B Gans Betty Meyboom-de Jong Henk J G Bilo

OBJECTIVE Chromium treatment has been reported to improve glycemic control in patients with type 2 diabetes. However, concern exists about the possible toxic effects of chromium picolinate. The aim of this study was to determine the effect of chromium treatment in the form of chromium yeast on glycemic control in a Western population of patients with type 2 diabetes who were being treated with ...

Journal: :Journal of bacteriology 1969
J W Shands V Miller H Martin V Senterfitt

The mechanism of the hypoglycemic activity of endotoxin in hyperreactive BCG mice was investigated. The mechanism was found to be an inhibition of the synthesis of glucose from noncarbohydrate sources. The possibilities of an induced hypermetabolic state and an induced release of insulin in response to endotoxin as causes for the hypoglycemic response were essentially ruled out. In addition, no...

Journal: :The Proceedings of the Nutrition Society 1966
E M Wilson

Fig. I shows a scheme for the treatment of diabetes in relation to the patient’s ability to produce endogenous insulin. If the amount of available insulin is large, treatment is by diet alone ; if moderate, it is by diet plus an oral hypoglycaemic agent, and if little or no insulin is being secreted, by diet plus insulin. Diabetics in groups I , 2 and 3 are therefore insulin-independent and tho...

Journal: :Indian journal of psychology 1958
E R DIVAKARAN S BANERJEE

Journal: :The Biochemical journal 1975
P A Halban R E Offord

1. This paper describes the semisynthesis of [3H]insulin of high specific radioactivity which is indistinguishable from native insulin in its hypoglycaemic activity towards mice. 2. The maximum specific radioactivity so far obtained is 20 Ci/mmol. At this value the recommended scale of preparation is between 1 mCi (30 mug of product) and 10mCi (300 mug of product). Reaction volumes are then of ...

2015
Christine Y Lu Isabel Cristina M Emmerick Peter Stephens Dennis Ross-Degnan Anita K Wagner

OBJECTIVES New antidiabetic medications such as insulin analogues and thiazolidinediones have been introduced over the last decade. This study compares the uptake of new agents in three emerging pharmaceutical markets: Brazil, China, and Thailand. METHODS Using longitudinal IMS Health sales data, we calculated the quarterly percentage market share for types of insulins and oral hypoglycemic a...

2012
Yi-Ning Yang Xiang Xie Yi-Tong Ma Xiao-Mei Li Zhen-Yan Fu Xiang Ma Ding Huang Bang-Dang Chen Fen Liu Ying Huang Cheng Liu Ying-Ying Zheng Gulinaer Baituola Zi-Xiang YU You Chen

BACKGROUND The aim of this study was to estimate the prevalence and distribution of type 2 diabetes and to determine the status of type 2 diabetes awareness, treatment, and control in Xinjiang, China. Our data came from the Cardiovascular Risk Survey (CRS) study designed to investigate the prevalence and risk factors for cardiovascular diseases in Xinjiang from October 2007 to March 2010. A tot...

Journal: :research journal of pharmacognosy 2014
s.e. sadat-ebrahimi m. hassanpoor mir g.r. amin h. hajimehdipoor

securigera securidaca (l.) degen & dorfl grows in different parts of iran. the seeds of the species are used in iranian folk medicine as an anti-diabetic agent. many studies have established hypoglycemic effects of amino acids and in the present investigation, amino acids of securigera securidaca seeds have been evaluated. the ground seeds were extracted using petroleum ether, hot ethanol a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید